Considering tapentadol as a first-line analgesic: 14 questions.

about

Considering tapentadol as a first-line analgesic: 14 questions.

Item

http://www.wikidata.org/entity/Q53339459

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Considering tapentadol as a first-line analgesic: 14 questions.

@en

Considering tapentadol as a first-line analgesic: 14 questions.

@nl

type

Item

label

Considering tapentadol as a first-line analgesic: 14 questions.

@en

Considering tapentadol as a first-line analgesic: 14 questions.

@nl

prefLabel

Considering tapentadol as a first-line analgesic: 14 questions.

@en

Considering tapentadol as a first-line analgesic: 14 questions.

@nl

P1476

Considering tapentadol as a first-line analgesic: 14 questions.

@en

P2093

Frank Breve

http://www.w3.org/2001/XMLSchema#string

Jo Ann LeQuang

http://www.w3.org/2001/XMLSchema#string

Joseph V Pergolizzi

http://www.w3.org/2001/XMLSchema#string

Robert B Raffa

http://www.w3.org/2001/XMLSchema#string

Robert Taylor

http://www.w3.org/2001/XMLSchema#string

Stephani E Strasburger

http://www.w3.org/2001/XMLSchema#string

P2860

Applications of CYP450 testing in the clinical setting

Neuropathic low back pain in clinical practice

Mechanistic and functional differentiation of tapentadol and tramadol

Comparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System.

Combining opioid and adrenergic mechanisms for chronic pain.

Treatment of painful diabetic neuropathy

Burning through the pain: treatments for diabetic neuropathy.

Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse.

Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects.

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.

P304

331-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PMT-2016-0063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28434283

http://www.w3.org/2001/XMLSchema#string